Brief: Shinpoong Pharmaceutical signs contract worth 2.52 bln won
28/03/2018 05:00
March 28 (Reuters) - Shinpoong Pharmaceutical Co Ltd
019170.KS :
* Says it signed a 2.52 billion won contract with Surgipharm
Limited to provide antimalarial medicine in Africa Kenya
Source text in Korean : https://goo.gl/yFhVab
Further company coverage: 019170.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on SHINPOONG PHARMACEUTICAL
See all newsBrief: Shinpoong Pharmaceutical To Divest 11.5 Billion Won Worth Of Own Shares
Brief: Shinpoong Pharmaceutical To Invest 62.4 Billion Won In Facilities
Brief: Shinpoong Pharmaceutical Co Wins 10 Billion Won Order
Brief: Shinpoong Pharmaceutical Wins 13 Billion Won Order
Brief: Shinpoong Pharmaceutical Applies For 3Rd Phase Clinical Trial Approval For Osteoarthritis Injection Treatment From S.Korea Ministry Of Food And Drug Safety